Doublecortin domain-containing protein 2C (DCDC2C)

Doublecortin domain-containing protein 2C (DCDC2C) is a member of the doublecortin (DCX) domain protein family, which are generally implicated in microtubule binding and stabilization, especially in the cytoskeleton and neuronal development[3][7][4]. For DCDC2C specifically, available evidence is limited to predictive annotations, with possible roles in intracellular signal transduction and localization to the cytoplasm and sperm flagellum[4][7]. There is no direct evidence of DCDC2C being a therapeutic target, nor documented small molecule or biologic ligands. The gene is listed in several databases with basic information, but lacks experimental validation of function, tissue specificity, or disease roles. Notes on correctness: - DCDC2C is listed as a *predicted* gene with limited functional evidence and is sometimes referred to as a "pseudogene" in certain sources, indicating there may be doubt as to whether it encodes a functional protein product in humans[7]. - It is not established in drug discovery or clinical literature as a therapeutic target. - There is a related and well-characterized gene DCDC2 (Doublecortin domain-containing protein 2), which is different from DCDC2C[1][5][6]. Care should be taken not to confuse the two.

Other names

Doublecortin domain containing 2CDCDC2Cdoublecortin domain containing 2C pseudogene